Yazarlar
W. David Arnold, Department of Neurology,
Division of Neuromuscular Medicine, The
Ohio State University Medical Center,
Columbus, OH, USA
Maxwell S. Damian, Cambridge University
Hospitals Department of Neurology,
Addenbrooke’s Hospital Neurosciences
Critical Care Unit, Cambridge, UK
Steven K. Baker, Department of Medicine,
Physical Medicine and Neurology,
Neuromuscular Disease Clinic, McMaster
University Medical Center, McMaster
University, Hamilton, Ontario, Canada
Mazen M. Dimachkie, Neuromuscular Section,
Department of Neurology, University of
Kansas Medical Center,Kansas City, KS, USA
Nikhil Balakrishnan, Wake Forest University
Baptist Medical Center, Winston Salem, NC, USA
Richard J. Barohn, Department of Neurology,
University of Kansas Medical Center,
Kansas City, KS, USA
James Burge, MRC Centre for Neuromuscular
Diseases, and National Hospital for Neurology
and Neurosurgery, UCLH FT, London, UK
Kate Bushby, Institute of Genetic Medicine,
International Centre for Life, Newcastle
upon Tyne, UK
Jean-Pierre Bouchard, Department of
Neurological Sciences, Université Laval, CHA
Hôpital Enfant-Jésus, Québec, Canada
Kristine Chapman, Division of Neurology,
University of British Columbia, Vancouver,
British Columbia, BC, Canada
Amy Chen, Department of Neurology,
University of Rochester, Rochester, NY, USA
Emma Ciafaloni, Department of Neurology,
University of Rochester, Rochester, NY, USA
Nigel Clarke, Institute for Neuroscience and
Muscle Research, The Children’s Hospital
at Westmead, Sydney Medical School,
University of Sydney, Sydney, NSW, Australia
James C. Cleland, Auckland City Hospital and
University of Auckland School of Medicine,
Auckland, New Zealand
Annie Dionne, Department of Neurological
Sciences, Université Laval, CHA Hôpital
Enfant-Jésus, Québec, Canada
Valentina Emmanuele, Department of
Neurology, Columbia University Medical
Center, New York, NY, USA
Andrew G. Engel, Department of Neurology,
Mayo Clinic, Rochester, MN, USA
Constantine Farmakidis, Columbia University
Medical Center, Neurological Institute, New
York, NY, USA
Steven A. Greenberg, Department of Neurology,
Brigham and Women’s Hospital and Harvard
Medical School, Boston, MA, USA
Michela Guglieri, Institute of Genetic
Medicine, International Centre for Life,
Newcastle upon Tyne, UK
Michael G. Hanna, MRC Centre for
Neuromuscular Diseases, and National
Hospital for Neurology and Neurosurgery,
UCLH FT, London, UK
Chad R. Heatwole, Department of Neurology,
University of Rochester Medical Center, NY, USA
Michael K. Hehir, Department of Neurology,
University of Rochester, Rochester, NY, USA
David N. Herrmann, Department of
Neurology, University of Rochester Medical
Center, Rochester, NY, USA
David Hilton-Jones, Department of Clinical
Neurology, University of Oxford, and John
Radcliffe Infirmary, Oxford, UK
vii